J. Czeczot

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Andy Gray, Brian Godman, Ilse Truter, 2015, Expert review of clinical pharmacology.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

M. Connock, R. Edlin, C. McCabe, 2011, Health technology assessment.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.

M. Connock, R. Edlin, C. McCabe, 2011, Health technology assessment.